Skip to Content
Quarter-End Insights

Healthcare Sector Less Appealing After Market Rebound

Changes to U.S. healthcare policy no longer a major fear.

Mentioned: , ,

Morningstar's US Healthcare Index has increased 12% over the trailing 12 months, as global concerns regarding the coronavirus eased significantly in the second quarter. Additionally, the returns have outperformed the broader equity market performance of an 8% gain. We believe the solid underlying fundamentals of the healthcare sector are supporting the returns. Also, the defensive nature of healthcare is likely supporting relative returns, as concerns around recessions and other coronavirus impacts weigh more heavily on other sectors. On the policy front, we expect investor attention to return to potential changes in the U.S. with the upcoming elections. However, the fears of major healthcare policy change in the U.S. appear to have faded, with the more moderate Joe Biden the presumptive Democratic nominee for president.


Healthcare sector index versus market index. - source: Morningstar

Damien Conover does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.